www.bioscience.co.uk
Sales & Support: +44 (0)1223 316 855

*

C1q, Mouse, mAb JL-1

Catalogue number:
HM1096-100UG
Supplier:
Size:
100 µg _$$_
Product is available in:
  • UK
  • Ireland
  • Europe
  • USA
  • Rest of World
£505.00 Shipping is calculated in checkout
Applications:

Frozen sections, Functional studies, Immuno assays, Immuno fluorescence, Western blot

Immunogen:

Purified mouse C1q

Product Description:

The monoclonal antibody JL-1 recognizes the collagen-like region (CLR) of mouse C1q, a 459 kDa molecule consisting of three individual polypeptide chains. The antibody has been generated by immunization of C1q-/- C57BL/6 mice with purified mouse C1q.C1q forms together with C1r and C1s the C1 macromolecule, the first component of the classical complement pathway. Interaction of immune complexes with C1q induces a conformational change within the C1 complex, which results in activation of the classical pathway. C1q functions as recognition unit by binding to the heavy chain of IgG or IgM (Fc gamma and Fc micro) provided that the immunoglobulins are bound to their antigen. Furthermore, C1q can also recognize molecular patterns associated with pathogens and it can bind to apoptotic blebs, where it activates the classical complement pathway and mediates phagocytosis. As such, C1q promotes the clearance of apoptotic cells and subsequent exposure of auto antigens, thereby preventing stimulation of the immune system.C1q is predominantly produced by macrophages but also by follicular dendritic cells, interdigitating cells and cells of the monocyte-macrophage lineage. C1q deficiency has a profound effect on host defence and clearance of immune complexes. Absence of C1q may cause autoimmunity by impairment of the clearance of apoptotic cells. Inherited C1q deficiency is also associated with the development of systemic lupus erythematosus (SLE).The monoclonal antibody JL-1 is reactive with the collagen-like region (CLR) only, which is the same region to which autoantibodies in mice and humans are binding. Anti-C1q autoantibodies deposit in glomeruli together with C1q but induce overt renal disease only in the context of glomerular immune complex disease. This provides an explanation why anti-C1q antibodies are especially pathogenic in patients with SLE.

HM1096-100UG C1q, Mouse, mAb JL-1
HM1096-100UG C1q, Mouse, mAb JL-1
Details Cat number & supplier Size Price
C5, Mouse, mAb BB5.1 HM1073-100MG · Hycult Biotech
HM1073-100MG
Hycult Biotech
100 mg £43847.00
100 mg
view
Activated C3, Human, mAb I3/15 HM2257-100UG · Hycult Biotech
HM2257-100UG
Hycult Biotech
100 µg £316.00
100 µg
view
Properdin, Human, mAb 1G6D2 HM2354-100UG · Hycult Biotech
HM2354-100UG
Hycult Biotech
100 µg £410.00
100 µg
view
C5/C5a, Human, mAb 561 HM2076-100UG · Hycult Biotech
HM2076-100UG
Hycult Biotech
100 µg £410.00
100 µg
view
C3/C3a, Human, mAb 2898 HM2075-100UG · Hycult Biotech
HM2075-100UG
Hycult Biotech
100 µg £410.00
100 µg
view
C3a/C3a des Arg, Human, mAb 2991 HM2074-100UG · Hycult Biotech
HM2074-100UG
Hycult Biotech
100 µg £410.00
100 µg
view
C3c, Human, mAb F1-4 HM2318-100UG · Hycult Biotech
HM2318-100UG
Hycult Biotech
100 µg £452.00
100 µg
view
C3b/iC3b, Human, mAb 3E7 HM2286-100UG · Hycult Biotech
HM2286-100UG
Hycult Biotech
100 µg £505.00
100 µg
view
C3b/iC3b, Human, mAb 5G9 HM2285-100UG · Hycult Biotech
HM2285-100UG
Hycult Biotech
100 µg £505.00
100 µg
view
C9 neoantigen, Human, mAb WU13-15 HM2264-100UG · Hycult Biotech
HM2264-100UG
Hycult Biotech
100 µg £452.00
100 µg
view